Navigation Links
Health Briefs TV Features SFJ Pharmaceuticals
Date:9/20/2013

Coral Springs, FL (PRWEB) September 20, 2013

The producers of Health Briefs TV are pleased to announce that SFJ Pharmaceuticals will be featured in an upcoming segment on "Innovative Drug Development and Clinical Research Driving Improved Patient Care" as part of the show's Medical Minutes series.

Their value of pharmaceuticals is especially evident in the field of oncology, where the speed of development and availability of drugs may offer the first ever treatment, or have significant advantages over existing drugs. With the costs of developing a cancer drug reaching up to one billion dollars, however, many pharmaceutical companies are using a step-by-step approach. They first advance their most promising drugs for one cancer type, line of therapy or stage, and then advance for additional cancer types, lines of therapy or stages, thus delaying the time it takes for life-saving and life-enhancing to get into the hands or physicians and patients.

Additionally, drugs are first developed for the largest markets, like breast and lung cancer. Drugs for other cancer types, like thyroid and kidney, are not as aggressively developed. Years may go by while patients in need wait, without access to life-saving or life-enhancing drugs.

Pleasanton, California-headquartered SFJ Pharmaceuticals has developed a revolutionary model to overcome drug development challenges. The company captures the lost value for pharmaceutical companies and patients, by taking drugs which are proven in one type of cancer, and helping to accelerate them through clinical development for many different types and stages of cancer.

The five-minute Health Briefs TV segment will educate viewers on the importance of efficient drug development, and will feature the innovative model developed by SFJ Pharmaceuticals to make drugs available to more patients, sooner. The segment will highlight several of SFJ's partnerships, including Eisai Pharmaceuticals for Phase III development of their drug, Lenvatinib, to treat 131I-Refractory Differentiated Thyroid Cancer; Pfizer's drug, Dacomitinib, for first-line treatment of non-small cell lung cancer; and Pfizer's drug, Axitinib, for the adjuvant treatment of renal cell carcinoma. For more information about SFJ Pharmaceuticals, please visit http://www.sfj-pharma.com.

Read the full story at http://www.prweb.com/releases/health-briefs-tv-and-sfj/pharmaceuticals-seg/prweb11138064.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Bel Marra Health Reports on Recent Research Finding Prolonged Life in Those Who Receive Corrective Eye Surgery
2. Online USA Doctors/Virtual Doctors Creates Comprehensive Female Health Plan That Prevents Premature Death in Postmenopausal Women
3. Diet Doc Hormone Diets & Weight Loss Plans Now Helps Clients Achieve a Healthy Lifestyle and Eliminate Causes of Weight Gain With Exclusive Diet Pills
4. Gorman Health Group Expert to Outline the Components of a Successful Medicare Advantage Risk-Adjustment Program
5. Zion Health Announces Native Remedy; Ancient Clay Soaps for Sensitive Skin; New Addition to Whole Foods Market Body Care in Andover, MA
6. Best Natural Acne Treatment Review Published by Health Company
7. School of Public Health Receives $390,000 Grant to Study Alcohol Use Among Youth Acquiring HIV
8. CHL to Hold Original Thought-Leadership Series about Need for Hispanics in the Healthcare and Biomedical Fields; City of Hope to Host Signature Event on Their Campus
9. CDPHP Health Plans Ranked As Best in New York State
10. Oakwood Medical Avatar Brings Personalized Health Info to Mobile Devices
11. Online USA Doctors Announces a New Online, Medical Record System That Improves Patient Health Outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal ... personalized through a fitness app. The fitness app plans to fix the two major problems ... offer a one size fits all type program , They don’t eliminate all ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... ANDOVER, Mass. and SAN CLEMENTE, Calif. ... California -based mobile pulmonary function testing company, is now ... portable PFT devices developed by ndd Medical Technologies , Inc. ... PFT testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ... CA , can get any needed testing done in the ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
Breaking Medicine Technology: